Addressing schemes of self-monitoring of blood glucose in type 2 diabetes

A European perspective and expert recommendation

Oliver Schnell, Hasan Alawi, Tadej Battelino, Antonio Ceriello, Peter Diem, Anne Felton, Wladyslaw Grzeszczak, Kari Harno, P. Kempler, Ilhan Satman, Bruno Vergès

Research output: Contribution to journalArticle

37 Citations (Scopus)

Abstract

Self-monitoring of blood glucose (SMBG) in type 2 diabetes has increasingly been shown to display beneficial effects on glycemic control. SMBG is not only associated with a reduction of hemoglobin A1c but has also been demonstrated to increase patients' awareness of the disease. SMBG has also the potential to visualize and predict hypoglycemic episodes. International guidelines by the International Diabetes Federation, the European Society of Cardiology, and the European Association for the Study of Diabetes and also the International Society for Pediatric and Adolescent Diabetes emphasize that SMBG is an integral part of self-management. More recently, two European consensus documents have been published to give recommendations for frequency and timing of SMBG also for various clinical scenarios. Recently, a European expert panel was held to further facilitate and enhance standardized approaches to SMBG. The aim was to present simple, clinically meaningful, and standardized SMBG strategies for type 2 diabetes. The panel recommended a less intensive and an intensive scheme for SMBG across the type 2 diabetes continuum. The length and frequency of SMBG performance depend on the clinical circumstances and the quality of glycemic control. The expert panel also recommended further evaluation of various schemes for SMBG in type 2 diabetes in clinical studies.

Original languageEnglish
Pages (from-to)959-965
Number of pages7
JournalDiabetes Technology and Therapeutics
Volume13
Issue number9
DOIs
Publication statusPublished - Sep 1 2011

Fingerprint

Blood Glucose Self-Monitoring
Type 2 Diabetes Mellitus
Self Care
Hypoglycemic Agents
Quality Control
Hemoglobins
Guidelines

ASJC Scopus subject areas

  • Endocrinology
  • Endocrinology, Diabetes and Metabolism
  • Medical Laboratory Technology

Cite this

Addressing schemes of self-monitoring of blood glucose in type 2 diabetes : A European perspective and expert recommendation. / Schnell, Oliver; Alawi, Hasan; Battelino, Tadej; Ceriello, Antonio; Diem, Peter; Felton, Anne; Grzeszczak, Wladyslaw; Harno, Kari; Kempler, P.; Satman, Ilhan; Vergès, Bruno.

In: Diabetes Technology and Therapeutics, Vol. 13, No. 9, 01.09.2011, p. 959-965.

Research output: Contribution to journalArticle

Schnell, O, Alawi, H, Battelino, T, Ceriello, A, Diem, P, Felton, A, Grzeszczak, W, Harno, K, Kempler, P, Satman, I & Vergès, B 2011, 'Addressing schemes of self-monitoring of blood glucose in type 2 diabetes: A European perspective and expert recommendation', Diabetes Technology and Therapeutics, vol. 13, no. 9, pp. 959-965. https://doi.org/10.1089/dia.2011.0028
Schnell, Oliver ; Alawi, Hasan ; Battelino, Tadej ; Ceriello, Antonio ; Diem, Peter ; Felton, Anne ; Grzeszczak, Wladyslaw ; Harno, Kari ; Kempler, P. ; Satman, Ilhan ; Vergès, Bruno. / Addressing schemes of self-monitoring of blood glucose in type 2 diabetes : A European perspective and expert recommendation. In: Diabetes Technology and Therapeutics. 2011 ; Vol. 13, No. 9. pp. 959-965.
@article{b68d83f9ed994bea865b07e09cff1425,
title = "Addressing schemes of self-monitoring of blood glucose in type 2 diabetes: A European perspective and expert recommendation",
abstract = "Self-monitoring of blood glucose (SMBG) in type 2 diabetes has increasingly been shown to display beneficial effects on glycemic control. SMBG is not only associated with a reduction of hemoglobin A1c but has also been demonstrated to increase patients' awareness of the disease. SMBG has also the potential to visualize and predict hypoglycemic episodes. International guidelines by the International Diabetes Federation, the European Society of Cardiology, and the European Association for the Study of Diabetes and also the International Society for Pediatric and Adolescent Diabetes emphasize that SMBG is an integral part of self-management. More recently, two European consensus documents have been published to give recommendations for frequency and timing of SMBG also for various clinical scenarios. Recently, a European expert panel was held to further facilitate and enhance standardized approaches to SMBG. The aim was to present simple, clinically meaningful, and standardized SMBG strategies for type 2 diabetes. The panel recommended a less intensive and an intensive scheme for SMBG across the type 2 diabetes continuum. The length and frequency of SMBG performance depend on the clinical circumstances and the quality of glycemic control. The expert panel also recommended further evaluation of various schemes for SMBG in type 2 diabetes in clinical studies.",
author = "Oliver Schnell and Hasan Alawi and Tadej Battelino and Antonio Ceriello and Peter Diem and Anne Felton and Wladyslaw Grzeszczak and Kari Harno and P. Kempler and Ilhan Satman and Bruno Verg{\`e}s",
year = "2011",
month = "9",
day = "1",
doi = "10.1089/dia.2011.0028",
language = "English",
volume = "13",
pages = "959--965",
journal = "Diabetes Technology and Therapeutics",
issn = "1520-9156",
publisher = "Mary Ann Liebert Inc.",
number = "9",

}

TY - JOUR

T1 - Addressing schemes of self-monitoring of blood glucose in type 2 diabetes

T2 - A European perspective and expert recommendation

AU - Schnell, Oliver

AU - Alawi, Hasan

AU - Battelino, Tadej

AU - Ceriello, Antonio

AU - Diem, Peter

AU - Felton, Anne

AU - Grzeszczak, Wladyslaw

AU - Harno, Kari

AU - Kempler, P.

AU - Satman, Ilhan

AU - Vergès, Bruno

PY - 2011/9/1

Y1 - 2011/9/1

N2 - Self-monitoring of blood glucose (SMBG) in type 2 diabetes has increasingly been shown to display beneficial effects on glycemic control. SMBG is not only associated with a reduction of hemoglobin A1c but has also been demonstrated to increase patients' awareness of the disease. SMBG has also the potential to visualize and predict hypoglycemic episodes. International guidelines by the International Diabetes Federation, the European Society of Cardiology, and the European Association for the Study of Diabetes and also the International Society for Pediatric and Adolescent Diabetes emphasize that SMBG is an integral part of self-management. More recently, two European consensus documents have been published to give recommendations for frequency and timing of SMBG also for various clinical scenarios. Recently, a European expert panel was held to further facilitate and enhance standardized approaches to SMBG. The aim was to present simple, clinically meaningful, and standardized SMBG strategies for type 2 diabetes. The panel recommended a less intensive and an intensive scheme for SMBG across the type 2 diabetes continuum. The length and frequency of SMBG performance depend on the clinical circumstances and the quality of glycemic control. The expert panel also recommended further evaluation of various schemes for SMBG in type 2 diabetes in clinical studies.

AB - Self-monitoring of blood glucose (SMBG) in type 2 diabetes has increasingly been shown to display beneficial effects on glycemic control. SMBG is not only associated with a reduction of hemoglobin A1c but has also been demonstrated to increase patients' awareness of the disease. SMBG has also the potential to visualize and predict hypoglycemic episodes. International guidelines by the International Diabetes Federation, the European Society of Cardiology, and the European Association for the Study of Diabetes and also the International Society for Pediatric and Adolescent Diabetes emphasize that SMBG is an integral part of self-management. More recently, two European consensus documents have been published to give recommendations for frequency and timing of SMBG also for various clinical scenarios. Recently, a European expert panel was held to further facilitate and enhance standardized approaches to SMBG. The aim was to present simple, clinically meaningful, and standardized SMBG strategies for type 2 diabetes. The panel recommended a less intensive and an intensive scheme for SMBG across the type 2 diabetes continuum. The length and frequency of SMBG performance depend on the clinical circumstances and the quality of glycemic control. The expert panel also recommended further evaluation of various schemes for SMBG in type 2 diabetes in clinical studies.

UR - http://www.scopus.com/inward/record.url?scp=80052052775&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80052052775&partnerID=8YFLogxK

U2 - 10.1089/dia.2011.0028

DO - 10.1089/dia.2011.0028

M3 - Article

VL - 13

SP - 959

EP - 965

JO - Diabetes Technology and Therapeutics

JF - Diabetes Technology and Therapeutics

SN - 1520-9156

IS - 9

ER -